Macitentan tablets are an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension in adults to reduce the risks of disease progression and hospitalisation, the company said.
Macitentan tablets are an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension in adults to reduce the risks of disease progression and hospitalisation, the company said.